Arctic Bioscience AS (OSL:ABS) EBIT per Share : kr-1.84 (TTM As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Arctic Bioscience AS EBIT per Share?

Arctic Bioscience AS's EBIT per Share for the six months ended in Jun. 2024 was kr-0.88. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 was kr-1.84.

During the past 3 years, the average EBIT per Share Growth Rate was -28.90% per year. During the past 5 years, the average EBIT per Share Growth Rate was -113.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Arctic Bioscience AS's EBIT per Share or its related term are showing as below:

OSL:ABS' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -228.6 Med: -129.1 Max: -28.9
Current: -28.9

During the past 6 years, the highest 3-Year average EBIT per Share Growth Rate of Arctic Bioscience AS was -28.90% per year. The lowest was -228.60% per year. And the median was -129.10% per year.

OSL:ABS's 3-Year EBIT Growth Rate is ranked worse than
81.68% of 1250 companies
in the Biotechnology industry
Industry Median: 2.8 vs OSL:ABS: -28.90

Arctic Bioscience AS's EBIT for the six months ended in Jun. 2024 was kr-22.23 Mil.

Arctic Bioscience AS EBIT per Share Historical Data

The historical data trend for Arctic Bioscience AS's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arctic Bioscience AS EBIT per Share Chart

Arctic Bioscience AS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-0.15

-0.91

-1.74

-1.39

-1.75

Arctic Bioscience AS Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EBIT per Share	Get a 7-Day Free Trial						-0.60	-0.79	-0.79	-0.96	-0.88

Arctic Bioscience AS EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Arctic Bioscience AS's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-44.522	/	25.427
=	-1.75

Arctic Bioscience AS's EBIT per Share for the quarter that ended in Jun. 2024 is calculated as

	EBIT per Share		(Q: Jun. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-22.229	/	25.286
=	-0.88

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr-1.84

Arctic Bioscience AS (OSL:ABS) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Arctic Bioscience AS EBIT per Share Related Terms

Thank you for viewing the detailed overview of Arctic Bioscience AS's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Arctic Bioscience AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arctic Bioscience AS (OSL:ABS) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Industrivegen 42, Orsta, NOR, 6155

Website

https://www.arctic-bioscience.com

Arctic Bioscience AS is a Norwegian biotechnology company. The company is focused on developing products and solutions based on bioactive marine compounds. The product portfolio includes nutraceuticals and pharmaceuticals. It is currently developing a novel, cost-efficient oral treatment (HRO350) for mild-to-moderate psoriasis. Its nutraceutical products are sold globally to both B2C and B2B under the Romega brand. The company operates in Norway, Europe, Australia and APAC.

Arctic Bioscience AS Headlines

No Headlines